Skip to Main Content

Paper Details

Characterization and implications of the initial estimated glomerular filtration rate 'dip' upon sodium-glucose cotransporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial.
Kidney Int
102
2021
cardiovascular, empagliflozin, glucose, heart failure, kidney disease, participants, patients, sodium-, sodium-glucose co-transporter-2, sodium-glucose cotransporter-2, type 2 diabetes
Author NameAffiliation
David Z I CherneyUniversity Health Network, University of Toronto
Naveed SattarInstitute of Cardiovascular and Medical Sciences, University of Glasgow
Bernard ZinmanLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and University of Toronto
  • 1 - 3

Datasets

Release 1.2